Part I: Diagnostic method patents in India

In March 2023, the Delhi High Court will consider two significant rejections by the Patent Office (PTO) that will determine the fate of diagnostic method patents in India. The PTO recently rejected EMD Millipore’s patent application involving IR based spectroscopy and Sequenom’s patent application involving non-invasive prenatal genetic diagnostics on the grounds that both inventions

... Continue Reading.

Part II: Diagnostic method patents in India

Part I provides factual context to the post below. Interpreting Section 3(i) Section 3 is the key section on “patent eligibility” and lists out what are not “inventions” under the Indian Patents Act. One such non-eligible patentable subject matter is listed in Section 3(i): “Any process for the medicinal, surgical, curative, prophylactic, diagnostic, therapeutic or

... Continue Reading.

SpicyIP Weekly Review (December 20- December 26)

Happy holidays to all our readers! After another eventful week on the blog, we are here with our weekly reviews summarizing the 5 posts covered on the blog along with 19 case summaries and other national and international IP developments. Highlights of the Week IP Reveries: Class 5.2 – Interrogating India’s Drug Regulation System Prof.

... Continue Reading.